1. Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug safety 2007;30:861-881.
2. Kirwan J, Power L. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Current opinion in rheumatology 2007;19:233-237.
3. Kirwan JR. In: Hochberg MC, editor. Systemic glucocorticoids in rheumatology. Rheumatology 2003;2nd ed. Edinburgh: Mosby. 385-392.
4. Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL. Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 2006;33:1651-1657.
5. Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 2006;81:1361-1367.
6. Buttgereit F, Burmester GR, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet 2005;365:801-803.